(Duke University) Researchers at Duke University have shown that a single systemic treatment using CRISPR genome editing technology can safely and stably correct a genetic disease — Duchenne muscular dystrophy (DMD) — for more than a year in mice, despite observed immune responses and alternative gene editing outcomes.

Original source: https://www.eurekalert.org/pub_releases/2019-02/du-sct021419.php